Work

Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle

Year: 2018

Type: article

Source: Neuropsychopharmacology

DOI: 10.1038/s41386-018-0050-8

Authors: Gustavo Gonzalez-Cuevas, Remi Martin-Fardon, Tony M. Kerr, David G. Stouffer, Loren H. Parsons, Dana C. Hammell, Stan L. Banks, Audra L. Stinchcomb, Friedbert Weiss

Institutions: Scripps Research Institute, Universidad Europea de Madrid, University of Maryland, Baltimore, Zynerba Pharmaceuticals (United States)

Language: English

Topic: Cannabis and Cannabinoid Research

Subfield: Pharmacology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Zynerba Pharmaceuticals, National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, National Institute on Drug Abuse

Awards: Implementation of novel methodology to study the anti-relapse potential of cannabidiol, Significance of withdrawal-related learning in EtOH craving and relapse, EtOH Seeking and Relapse: Therapeutic Potential of Transdermal Cannabidiol

OpenAlex ID: W2789955855

FWCI: 11.46

Cites: 87

Cited by: 157

Related to: 10